Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Nephrology

Symptoms and Complications of SHPT

At a Glance

Secondary hyperparathyroidism from kidney disease may be silent early, but persistent mineral imbalance can cause bone pain, weakness, itching, fractures, and blood-vessel calcification. Severe muscle spasms, heart symptoms, or painful dark skin lesions need urgent care.

Secondary hyperparathyroidism (SHPT) is often called a “silent” condition because, in its early stages, you may feel completely normal [1]. However, as the condition progresses alongside your kidney disease, it can begin to affect almost every part of your body, from your skeleton to your heart [2].

Recognizing the Symptoms

Because SHPT develops gradually, symptoms usually do not become noticeable until kidney function has significantly declined [1][3]. It is also important to note that many of these symptoms—like fatigue or weakness—have multiple causes, including anemia, neuropathy, or the kidney disease itself. Do not self-diagnose or change your medications based on symptoms alone; always discuss them with your team.

  • Early Stages: In Stage 3 CKD, SHPT is often symptom-free. Your doctor will track it primarily through routine blood work checking your calcium, phosphate, PTH, and Vitamin D levels [1].
  • Advanced Symptoms: As mineral imbalances persist for a long time, you may experience:
    • Bone and Joint Pain: A dull, aching pain in the hips, back, or legs [1][4].
    • Muscle Weakness: Difficulty getting out of a chair or climbing stairs [4].
    • Pruritus (Itching): Persistent, widespread itching that is not caused by a rash [1].
    • Fractures: Bones may break more easily from minor impacts [5][6].

Bone Complications: Renal Osteodystrophy

The term renal osteodystrophy describes the specific changes in bone quality and strength caused by kidney disease [7]. Bone fragility in CKD-MBD can happen for different reasons:

  • High-Turnover Bone Disease: High levels of PTH act like a “drill,” constantly pulling calcium out of your bones to keep blood levels stable [8]. Your bones are remodeled too quickly, making them structurally weak and prone to fractures [9][6]. In very severe, untreated cases, the shape of the bones can even change, though this is much less common today due to better monitoring [6][10].
  • Low-Turnover (Adynamic) Bone Disease: Alternatively, if PTH is suppressed too much by treatments, or due to other CKD factors, bones can become “quiet” and stop renewing themselves, which also leads to severe fragility. Standard osteoporosis can also coexist with these conditions.

Heart and Blood Vessel Complications

Another major complication of CKD-MBD is vascular calcification—the depositing of minerals inside the blood vessels [2]. This is a complex, multifactorial process. While high phosphate and calcium levels contribute to it, other factors like age, diabetes, dialysis exposure, and inflammation also play major roles [11].

  • Arterial Stiffness: As blood vessels accumulate calcium, they become less flexible. This forces your heart to work harder, which is associated with left-ventricular hypertrophy (thickening of the heart muscle) and an increased risk of cardiovascular events [12][13].
  • Soft-Tissue Calcification: Minerals can also build up around your joints (periarticular calcification), causing painful inflammation that can mimic an infection [14][15].

When to Seek Immediate Help

While SHPT is usually managed gradually, certain symptoms related to mineral imbalances require immediate medical attention.

Call Emergency Services (911) for:

  • Severe Electrolyte Symptoms: Sudden confusion, seizures, or dangerous heart rhythms (palpitations/arrhythmias). These can be signs of extreme calcium imbalances and are emergencies regardless of the cause [16][17].
  • Tetany: Severe, painful muscle spasms or “locking” of the muscles, often starting in the hands or around the mouth [16].
  • Acute Cardiac Symptoms: Sudden chest pain, severe shortness of breath, or fainting [18].

Contact Your Nephrology Team the SAME DAY for:

  • Signs of Calciphylaxis: This is a rare but life-threatening complication where small blood vessels in the skin become blocked. Contact your doctor immediately if you notice very painful, dark, or “mottled” skin patches that turn into open sores or black, crusty areas [19][20]. Do not try to diagnose this yourself; let a doctor evaluate the wound urgently.

Discuss at Your Next Routine Visit:

  • Gradual worsening of bone or joint pain.
  • Increased frequency of itching.
  • Slowly declining muscle strength or general fatigue.

Common questions in this guide

Can SHPT cause bone pain, weakness, or itching?
As renal secondary hyperparathyroidism advances, it can be associated with aching bone or joint pain, muscle weakness, persistent itching without a rash, and bones that fracture more easily. These symptoms can also result from anemia, nerve problems, or kidney disease itself, so blood tests and a clinician’s assessment are needed.
What is renal osteodystrophy, and why can it make bones fragile?
Renal osteodystrophy is a change in bone quality and strength caused by kidney disease. High parathyroid hormone levels can make bone renewal too fast, while overly suppressed levels can make renewal too slow; either pattern can weaken bones and increase fracture risk.
Can SHPT affect the heart and blood vessels?
Yes. In kidney-related mineral and bone disease, calcium and phosphate can contribute to mineral deposits in blood vessels, making arteries stiffer and increasing the heart’s workload. This is associated with thickening of the heart muscle and a higher risk of cardiovascular events, although age, diabetes, dialysis exposure, and inflammation also affect risk.
Which SHPT symptoms require emergency care?
Call emergency services for sudden confusion, seizures, a dangerous or irregular heartbeat, severe painful muscle spasms, chest pain, severe shortness of breath, or fainting. These symptoms may signal a serious calcium or other electrolyte problem and need urgent evaluation regardless of the cause.
What skin changes could be signs of calciphylaxis?
Calciphylaxis is a rare, life-threatening complication in which small skin blood vessels become blocked. Very painful dark or mottled patches that develop into open sores or black, crusty areas need same-day contact with your nephrology team; do not assume they are a normal rash or diagnose them yourself.
How is SHPT monitored when there are no symptoms?
SHPT can be silent, especially in earlier kidney disease, so symptoms alone cannot rule it in or out. Clinicians monitor blood calcium, phosphate, parathyroid hormone, and vitamin D levels, and interpret the results alongside your kidney disease and overall health.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my labs, are my parathyroid hormone levels high enough to be causing my current bone pain or itching?
  2. 2.Do I have signs of vascular calcification on any of my recent imaging or heart tests?
  3. 3.How can we tell if my bone disease is 'high turnover' (from SHPT) or 'low turnover' (adynamic)?
  4. 4.Am I at an increased risk for calciphylaxis, and what should I look for beyond just a normal skin rash?
  5. 5.What are the target ranges for my calcium and phosphate to minimize my heart and bone risks?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    The Use of Imaging Techniques in Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD)-A Systematic Review.

    Pimentel A, Bover J, Elder G, et al.

    Diagnostics (Basel, Switzerland) 2021; (11(5)) doi:10.3390/diagnostics11050772.

    PMID: 33925796
  2. 2

    Combination of Biomarkers and Novel Diagnostic Tools in the Management of Osteoporosis in Chronic Kidney Disease: An Update.

    Mollica MV, Cianciolo G, Santoro C, et al.

    Journal of clinical medicine 2026; (15(12)) doi:10.3390/jcm15124712.

    PMID: 42355880
  3. 3

    Secondary hyperparathyroidism among Nigerians with chronic kidney disease.

    Gimba ZM, Abene EE, Agbaji OOO, Agaba EI

    African health sciences 2018; (18(2)):446-457 doi:10.4314/ahs.v18i2.30.

    PMID: 30602972
  4. 4

    Parathyroid Hormone: A Uremic Toxin.

    Duque EJ, Elias RM, Moysés RMA

    Toxins 2020; (12(3)) doi:10.3390/toxins12030189.

    PMID: 32192220
  5. 5

    Bilateral Olecranon and Left Lesser Trochanter Avulsion Fractures in Renal Osteodystrophy: A Rare Case Report and Comprehensive Review.

    Papineni VRK, Botchu R, Iyengar KP, et al.

    Acta medica Lituanica 2025; (32(2)):313-321 doi:10.15388/Amed.2025.32.2.1.

    PMID: 41659143
  6. 6

    Bone Health ECHO Case Report: High Bone Mass in a Patient with Chronic Kidney Disease.

    Belaya Z, Przhiyalkovskaya E, Mamedova E, et al.

    Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2025; (28(1)):101554 doi:10.1016/j.jocd.2024.101554.

    PMID: 39778461
  7. 7

    Brown tumor complicating end-stage kidney disease.

    Wiederkehr M

    Clinical nephrology. Case studies 2020; (8()):72-79 doi:10.5414/CNCS110195.

    PMID: 33062583
  8. 8

    Current Understanding of Mineral and Bone Disorders of Chronic Kidney Disease and the Scientific Grounds on the Use of Exogenous Parathyroid Hormone in Its Management.

    Pazianas M, Miller PD

    Journal of bone metabolism 2020; (27(1)):1-13 doi:10.11005/jbm.2020.27.1.1.

    PMID: 32190604
  9. 9

    Changing bone patterns with progression of chronic kidney disease.

    Drüeke TB, Massy ZA

    Kidney international 2016; (89(2)):289-302.

    PMID: 26806832
  10. 10

    Sixty-Two-Year-Old Male Suffering From Uremic Leontiasis Ossea Caused by Severe Secondary Hyperparathyroidism.

    Purrunsing Y, Zhang J, Cui Y, et al.

    JBMR plus 2018; (2(4)):240-245 doi:10.1002/jbm4.10038.

    PMID: 30283905
  11. 11

    The Bone-Vascular Axis: A Key Player in Chronic Kidney Disease Associated Vascular Calcification.

    Shen Y, Yu C

    Kidney diseases (Basel, Switzerland) 2024; (10(6)):545-557 doi:10.1159/000541280.

    PMID: 39664335
  12. 12

    CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.

    Reiss AB, Miyawaki N, Moon J, et al.

    Atherosclerosis 2018; (278()):49-59 doi:10.1016/j.atherosclerosis.2018.08.046.

    PMID: 30253289
  13. 13

    Mineral metabolism and cardiovascular disease in CKD.

    Fujii H, Joki N

    Clinical and experimental nephrology 2017; (21(Suppl 1)):53-63 doi:10.1007/s10157-016-1363-8.

    PMID: 28062938
  14. 14

    Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications.

    Kaur R, Singh R

    Life sciences 2022; (311(Pt B)):121148 doi:10.1016/j.lfs.2022.121148.

    PMID: 36336124
  15. 15

    Recurrent Inflammatory State due to Severe Periarticular Calcifications in a Patient on Hemodialysis: A Case Report.

    Timsans J, Vilpakka M, Lusila N, Kauppi M

    Clinical case reports 2025; (13(2)):e70205 doi:10.1002/ccr3.70205.

    PMID: 39967841
  16. 16

    Hungry Bone Syndrome After Parathyroidectomy for Secondary Hyperparathyroidism: Pathogenesis and Contemporary Clinical Considerations.

    Coman A, Tarta C, Marian M, et al.

    Journal of clinical medicine 2025; (14(19)) doi:10.3390/jcm14197104.

    PMID: 41096184
  17. 17

    Postparathyroidectomy calciphylaxis in a patient with primary hyperparathyroidism: a rare complication.

    Karki A, Alomari L, Halliday J, et al.

    JCEM case reports 2026; (4(3)):luag021 doi:10.1210/jcemcr/luag021.

    PMID: 41743175
  18. 18

    Uremic Cardiomyopathy: A New Piece in the Chronic Kidney Disease-Mineral and Bone Disorder Puzzle.

    de Albuquerque Suassuna PG, Sanders-Pinheiro H, de Paula RB

    Frontiers in medicine 2018; (5()):206 doi:10.3389/fmed.2018.00206.

    PMID: 30087898
  19. 19

    Calciphylaxis: risk factors, diagnosis, and treatment.

    Nigwekar SU, Kroshinsky D, Nazarian RM, et al.

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2015; (66(1)):133-46.

    PMID: 25960299
  20. 20

    Calciphylaxis Following Parathyroidectomy in Chronic Kidney Disease Patients-Case Report and Literature Review.

    Akad N, Bilha SC, Apetrii M, et al.

    Biomedicines 2025; (13(3)) doi:10.3390/biomedicines13030715.

    PMID: 40149691

This page explains symptoms and complications of secondary hyperparathyroidism related to kidney disease for informational purposes only and does not constitute medical advice. Contact your nephrology team about your symptoms, and seek urgent help for severe or sudden warning signs.

Get notified when new evidence is published on secondary hyperparathyroidism of renal origin.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.